A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis B

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2009
The purpose of this study is to determine whether Adefovir Dipivoxil is effective and safe in treatment of Chinese Patients with HBeAg positive Chronic Hepatitis B for 5 years.
Epistemonikos ID: 9ac05fbc4fe7b498cafca6807bacf71528da19bd
First added on: Nov 24, 2021